| 1 |
34785775 | Inhibition of cathepsin K sensitizes oxaliplatin-induced apoptotic cell death by Bax upregulation through OTUB1-mediated p53 stabilization in vitro and in vivo. | 2022 Jan |
2 |
| 2 |
35165262 | DNAJB8 in small extracellular vesicles promotes Oxaliplatin resistance through TP53/MDR1 pathway in colon cancer. | 2022 Feb 14 |
3 |
| 3 |
35178443 | Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53. | 2022 |
5 |
| 4 |
35584569 | BAP1 phosphorylation-mediated Sp1 stabilization plays a critical role in cathepsin K inhibition-induced C-terminal p53-dependent Bax upregulation. | 2022 Jul |
1 |
| 5 |
33662352 | Perifosine enhances the potential antitumor effect of 5-fluorourasil and oxaliplatin in colon cancer cells harboring the PIK3CA mutation. | 2021 May 5 |
2 |
| 6 |
33824865 | TRIM29 Reverses Oxaliplatin Resistance of P53 Mutant Colon Cancer Cell. | 2021 |
7 |
| 7 |
33922007 | Oxaliplatin-Induced Senescence in Colorectal Cancer Cells Depends on p14ARF-Mediated Sustained p53 Activation. | 2021 Apr 22 |
6 |
| 8 |
33963708 | [Synergistic effect of polysaccharide from Trichoderma pseudokoningii and oxaliplatin on colorectal cancer cells in vitro]. | 2021 Apr 20 |
1 |
| 9 |
33986248 | A KLF4/PiHL/EZH2/HMGA2 regulatory axis and its function in promoting oxaliplatin-resistance of colorectal cancer. | 2021 May 13 |
1 |
| 10 |
32163218 | Curcumin β-D-glucuronide exhibits anti-tumor effects on oxaliplatin-resistant colon cancer with less toxicity in vivo. | 2020 May |
2 |
| 11 |
32468080 | Protein expression profiling identifies differential modulation of homologous recombination by platinum-based antitumor agents. | 2020 Jun |
2 |
| 12 |
32622356 | Gallbladder cancer with EGFR mutation and its response to GemOx with erlotinib: a case report and review of literature. | 2020 Jul 4 |
1 |
| 13 |
32742376 | TP53 mutation influences the efficacy of treatment of colorectal cancer cell lines with a combination of sirtuin inhibitors and chemotherapeutic agents. | 2020 Aug |
1 |
| 14 |
32851091 | AURKA Increase the Chemosensitivity of Colon Cancer Cells to Oxaliplatin by Inhibiting the TP53-Mediated DNA Damage Response Genes. | 2020 |
1 |
| 15 |
32984059 | Dysregulated Phosphorylation of p53, Autophagy and Stemness Attributes the Mutant p53 Harboring Colon Cancer Cells Impaired Sensitivity to Oxaliplatin. | 2020 |
4 |
| 16 |
33251049 | LINC00460-miR-149-5p/miR-150-5p-Mutant p53 Feedback Loop Promotes Oxaliplatin Resistance in Colorectal Cancer. | 2020 Dec 4 |
5 |
| 17 |
30418550 | Urolithin A gains in antiproliferative capacity by reducing the glycolytic potential via the p53/TIGAR axis in colon cancer cells. | 2019 Mar 12 |
1 |
| 18 |
30596962 | Oligomeric proanthocyanidins (OPCs) from grape seed extract suppress the activity of ABC transporters in overcoming chemoresistance in colorectal cancer cells. | 2019 May 14 |
1 |
| 19 |
30724469 | Serine/arginine protein-specific kinase 2 promotes the development and progression of pancreatic cancer by downregulating Numb and p53. | 2019 May |
2 |
| 20 |
30792807 | Anticancer response to disulfiram may be enhanced by co-treatment with MEK inhibitor or oxaliplatin: modulation by tetrathiomolybdate, KRAS/BRAF mutations and c-MYC/p53 status. | 2019 |
1 |
| 21 |
30894685 | p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy. | 2019 Apr |
1 |
| 22 |
30898612 | Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals. | 2019 May |
1 |
| 23 |
30987009 | Luteolin Shifts Oxaliplatin-Induced Cell Cycle Arrest at G₀/G₁ to Apoptosis in HCT116 Human Colorectal Carcinoma Cells. | 2019 Apr 2 |
3 |
| 24 |
31002510 | Fuplatin: An Efficient and Low-Toxic Dual-Prodrug. | 2019 May 9 |
1 |
| 25 |
31436301 | Dehydrogenase/reductase SDR family member 2 silencing sensitizes an oxaliplatin‑resistant cell line to oxaliplatin by inhibiting excision repair cross‑complementing group 1 protein expression. | 2019 Nov |
1 |
| 26 |
29115606 | DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53‑deficient pancreatic cancer cells. | 2018 Jan |
2 |
| 27 |
29138869 | Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1. | 2018 Jan |
1 |
| 28 |
29378575 | Effects of Omegaven®, EPA, DHA and oxaliplatin on oesophageal adenocarcinoma cell lines growth, cytokine and cell signal biomarkers expression. | 2018 Jan 30 |
2 |
| 29 |
29896290 | A Study on Effect of Oxaliplatin in MicroRNA Expression in Human Colon Cancer. | 2018 |
3 |
| 30 |
29963241 | Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells. | 2018 Jun 12 |
2 |
| 31 |
29980405 | Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals. | 2018 Aug |
1 |
| 32 |
30029680 | Regulation of tNOX expression through the ROS-p53-POU3F2 axis contributes to cellular responses against oxaliplatin in human colon cancer cells. | 2018 Jul 20 |
16 |
| 33 |
30059758 | Chemosensitivity of human colon cancer cells is influenced by a p53-dependent enhancement of ceramide synthase 5 and induction of autophagy. | 2018 Oct |
5 |
| 34 |
28031409 | Functional Activation of Mutant p53 by Platinum Analogues in Cisplatin-Resistant Cells Is Dependent on Phosphorylation. | 2017 Mar |
2 |
| 35 |
28122359 | Tumor-associated NADH oxidase (tNOX)-NAD+-sirtuin 1 axis contributes to oxaliplatin-induced apoptosis of gastric cancer cells. | 2017 Feb 28 |
1 |
| 36 |
28284059 | Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin. | 2017 Apr |
1 |
| 37 |
28902369 | Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo. | 2017 Oct |
2 |
| 38 |
27609465 | Upregulation of CYP2S1 by oxaliplatin is associated with p53 status in colorectal cancer cell lines. | 2016 Sep 9 |
8 |
| 39 |
25534115 | ASPP2 enhances oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy. | 2015 Mar |
2 |
| 40 |
26146058 | [ASPP2 inhibits oxaliplatin-induced autophagy and promotes apoptosis of colon cancer cells]. | 2015 Jul |
2 |
| 41 |
26208523 | The 1,2-Diaminocyclohexane Carrier Ligand in Oxaliplatin Induces p53-Dependent Transcriptional Repression of Factors Involved in Thymidylate Biosynthesis. | 2015 Oct |
6 |
| 42 |
26490659 | Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy? | 2015 Oct 21 |
1 |
| 43 |
23821376 | Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT. | 2014 Jun |
2 |
| 44 |
24634414 | Metallothionein 1G and zinc sensitize human colorectal cancer cells to chemotherapy. | 2014 May |
1 |
| 45 |
25241782 | [Phosphorylation status of ASPP2 modulates p53 apoptotic function in oxaliplatin-induced apoptosis of colorectal cancer HCT116 cells]. | 2014 Jun |
3 |
| 46 |
25474278 | Prognostic value of microsatellite instability and p53 expression in metastatic colorectal cancer treated with oxaliplatin and fluoropyrimidine-based chemotherapy. | 2014 Dec |
2 |
| 47 |
23262037 | Negative regulation of transcription factor FoxM1 by p53 enhances oxaliplatin-induced senescence in hepatocellular carcinoma. | 2013 Apr 30 |
2 |
| 48 |
23504997 | Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion. | 2013 Aug |
1 |
| 49 |
23525071 | Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA. | 2013 Jul |
1 |
| 50 |
23754252 | Enhanced antitumor activity of cerulenin combined with oxaliplatin in human colon cancer cells. | 2013 Aug |
3 |